WeVote
Log In

Bill

Bill

HB 6855

AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING DRUG CONTROL AND CANNABIS AND HEMP REGULATION.

2025 Regular Session

HB 6855 updates and consolidates Connecticut’s regulation of controlled substances, cannabis, hemp, licensing, consumer protection, and enforcement to strengthen oversight and cons

SIGNED BY GOVERNOR
#advancedpracticenurses #advertising #beverages #certificatesandcertification #certificatesofoccupancy #civilactions #consumerprotectiondepartment #controlledsubstances #controlledsubstancesregistration #controlledsubstancesschedules #criminalhistoryrecords #electronicgovernmentinformation #fees #financialinstitutions #hearings #hemp #labeling #licenses #marijuana #nurses #patients #pharmacies #pharmacists #physicianassistants #physicians #reports #retailtrade #sales #signs #telemedicine #transporters #unfairordeceptivetradepractices #violations
0
WeVote Research Nonpartisan
Bill Summary · HB 6855

Summary — HB 6855

AN ACT CONCERNING THE DEPARTMENT OF CONSUMER PROTECTION'S RECOMMENDATIONS REGARDING DRUG CONTROL AND CANNABIS AND HEMP REGULATION
Public Act No. 25-101 (Signed by Governor)

Main purpose

HB 6855 implements a package of statutory changes based on recommendations from the Connecticut Department of Consumer Protection (DCP) to update and consolidate state law governing controlled substances, cannabis, hemp, and related licensing, consumer protection, and professional practice issues. The goals are to align regulatory structure with current market and public‑health realities, strengthen consumer protections and oversight, and clarify licensing/registration and enforcement authority.

Key provisions (by subject area)

Because the act is omnibus in nature, it addresses multiple regulatory topics listed in the bill title and subject index. Broad categories of change include:

  • Controlled substances and drug control

    • Revisions to scheduling, registration, and recordkeeping requirements for registrants (pharmacies, pharmacists, practitioners, transporters).
    • Updated processes for controlled substance prescriptions, including provisions affecting telemedicine prescribing and practitioner delegation.

  • Cannabis and hemp regulation

    • Modifications to licensing, labeling, advertising, and sale requirements for cannabis and hemp products.
    • Rules for transporters, testing, and labeling to address consumer safety and product integrity.
    • Prohibitions or clarifications around unfair and deceptive trade practices in cannabis/hemp retailing and advertising.

  • Professional practice and licensing

    • Changes affecting advanced practice nurses, physician assistants, pharmacists and pharmacies — including scope of practice, certification or registration changes, and potential telehealth-related adjustments.
    • Criminal history record checks and other qualifications for licensure/registration in regulated roles.

  • Consumer protection, fees and enforcement

    • Enhanced DCP enforcement tools, fee adjustments, reporting requirements, and administrative hearing processes.
    • Provisions addressing financial institutions, sale signage, and retailer obligations.

Who is affected

  • Patients and consumers of medical/recreational cannabis and hemp products
  • Pharmacies, pharmacists, physicians, advanced practice nurses, physician assistants
  • Cannabis/hemp businesses: cultivators, manufacturers, retailers, testing labs, transporters
  • Law enforcement and regulatory agencies (DCP)
  • Financial institutions and other entities providing services to cannabis/hemp businesses

Procedural / timeline notes

  • Introduced: February 5, 2025
  • Public hearing: February 14, 2025
  • Reported favorably and amended through the legislative process in March–June 2025
  • Passed both chambers in early June 2025
  • Transmitted to Governor June 23, 2025; signed into law June 24, 2025
  • Enacted as Public Act No. 25-101

Implementation & considerations

The act is multi-topic; specific statutory amendments and effective dates are in the enrolled bill/Public Act text. Stakeholders (providers, businesses, licensing boards, enforcement agencies) should review the enacted language for compliance obligations, updated licensing/registration processes, fee changes, and any new recordkeeping or reporting requirements. For legal or operational decisions, consult the full Public Act and DCP guidance.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.